Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Significant Decline in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 541,500 shares, a drop of 47.9% from the February 28th total of 1,039,200 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average daily volume of 100 shares, the short-interest ratio is presently 5,415.0 days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Recordati Industria Chimica e Farmaceutica stock remained flat at $55.54 during mid-day trading on Friday. Recordati Industria Chimica e Farmaceutica has a 1-year low of $52.25 and a 1-year high of $52.25. The firm’s fifty day simple moving average is $55.54 and its 200 day simple moving average is $53.69. The company has a market capitalization of $11.46 billion, a P/E ratio of 27.77 and a beta of 0.30.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.